Provided By GlobeNewswire
Last update: Oct 28, 2025
Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL (abuse deterrent transdermal system) through commercialization.
Read more at globenewswire.comNASDAQ:NTRB (11/7/2025, 12:32:21 PM)
5.66
+0.13 (+2.35%)
NASDAQ:NTRBW (11/5/2025, 8:17:37 PM)
2.1
-0.51 (-19.54%)
Find more stocks in the Stock Screener


